Podcast Episodes
Back to Search
The Misinformation Maze: Navigating Public Health in the Digital Age
In this episode of the Pharmaceutical Executive podcast, Jennifer Butler, Chief Commercial Officer of Pleio, discusses: The threat of misinformation …
1 year, 4 months ago
Navigating Distrust: Pharma in the Age of Social Media
In this episode of the Pharmaceutical Executive Podcast, CEO and Founder of Sooth, Ian Baer, is back to discuss: The growing distrust in social medi…
1 year, 4 months ago
Revolutionizing Patient Adherence: Leveraging AI for Personalized Engagement
In this episode of the Pharmaceutical Executive podcast, Bill Grambley, CEO of AllazoHealth, delves into the potential of AI to revolutionize patient…
1 year, 5 months ago
The Future of Fertility: AI, Personalized Medicine, and Ethical Considerations
In this episode of the Pharmaceutical Executive podcast, Dr. Lawrence B. Werlin, MD, FACOG of HRC Fertility (@md.lawrence.werlin on TikTok), discusse…
1 year, 5 months ago
Key Findings of the NIAGARA and HIMALAYA Trials
In this episode of the Pharmaceutical Executive podcast, Shubh Goel, Head of Immuno-Oncology and Gastrointestinal Tumors, US Oncology Business Unit, …
1 year, 8 months ago
Fake Weight Loss Drugs: Growing Threat to Consumer Health
UpScriptHealth's Peter Ax, Founder and CEO, and George Jones, Chief Operations Officer, discuss: Counterfeit weight loss drugs (particularly fake Oze…
1 year, 8 months ago
A Different Approach to Dermatology Care
Brian Hillberdink, EVP, LEO Pharma and President of LEO Pharma's US affiliate, discusses how is they're positioning to capitalize on the unmet needs …
1 year, 9 months ago
Beyond the Birthrate: The Societal Costs of Maternal Morality
In this episode of the Pharmaceutical Executive podcast, Charlotte Owens, MD, FACOG, Head of Medical Affairs and Outcomes Research at Organon discuss…
1 year, 10 months ago
Empty Shelves, Urgent Solutions
Michael Abrams, Managing Partner at Numerof & Associates discusses pharmacy deserts and the main factors that are contributing to the closures of bot…
1 year, 11 months ago
The Weight-Loss Gold Rush: Legal and Regulatory Implications
Jim Shehan, chair of the FDA Regulatory practice, Lowenstein Sandler, discusses: Top legal and regulatory concerns for investors considering when fin…
2 years ago